Further analysis of tumor cell growth regulatory proteins indicated that receptor downregulation was associated with a decrease in the level of PKB/Akt, β-catenin, NF-κB, cyclin D1 and c-Myc [15,26]. The gene discussed is CCND1; the disease is neoplasm.